Market Overview

US Stock Futures Up Ahead Of Factory Orders Data

US Stock Futures Up Ahead Of Factory Orders Data
Related GPS
'Here Comes The Artic Freeze To U.S. Retailers,' Says Brian Sozzi
Here's Who Benefits The Most If Sears Goes Bankrupt
Gap Inc. Still A Dividend Favorite After Mini Rally (Seeking Alpha)
Related ZGNX
What Investors Are Watching Ahead of Zogenix's FDA Approval Decision
What Investors Should Expect From Rockwell Medical's Next FDA Decision
Egalet up on HAL study (Seeking Alpha)

Pre-open movers

US stock futures rose in early pre-market trade, ahead of factory orders data. Data on factory orders will be released at 10:00 a.m. ET. Futures for the Dow Jones Industrial Average surged 35 points to 15,577.00, while the Standard & Poor's 500 index futures rose 4.20 points to 1,758.90. Futures for the Nasdaq 100 index gained 12.75 points to 3,380.75.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.28%, London's FTSE 100 index gaining 0.48% and STOXX Europe 600 Index surging 0.36%. German DAX 30 index rose 0.33% and French CAC 40 Index gained 0.22%.

Asian markets ended mostly lower today. China's Shanghai Composite gained 0.07 points, Hong Kong's Hang Seng Index declined 0.26%. Australia's ASX/S&P500 fell 0.41%.

Broker Recommendation

Analysts at Goldman Sachs downgraded Gap (NYSE: GPS) from “buy” to “neutral.” The target price for Gap has been lowered from $42 to $40.

Gap's shares closed at $36.78 on Friday.

Breaking news

  • Zogenix (NASDAQ: ZGNX) announced today that it intends to offer and sell $60 million of shares of its common stock in an underwritten public offering. To read the full news, click here.
  • Sequential Brands Group (NASDAQ: SQBG) announced today that it has acquired the Franklin Mint brand, including all of the related intellectual property and certain other assets. To read the full news, click here.
  • Sangamo BioSciences (NASDAQ: SGMO) announced today the presentation of clinical data from its program to develop a ZFP Therapeutic® for HIV/AIDS. To read the full news, click here.
  • Spherix (NASDAQ: SPEX) announced today that the Company has accepted $2.0 million in subscriptions of a non-brokered private placement of its equity that convert into common stock on a share for share basis. To read the full news, click here.

Posted-In: Goldman Sachs US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (SGMO + GPS)

Around the Web, We're Loving...

Get Benzinga's Newsletters